Kailera Therapeutics Email Format

Biotechnology Research
51-200 employees
Waltham, MA, USA

Kailera Therapeutics is a biotechnology company developing clinical-stage injectable and oral therapies for the treatment of obesity and weight management.

Find contacts at Kailera Therapeutics

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@kailera.com

Company Overview

Industry
Biotechnology Research
Founded
2024
Headquarters
Waltham, MA, USA
Revenue
$25M-$50M
FUNDING Stage
Private
Key Executives
Ron Renaud (President & Chief Executive Officer), Doug Pagan (Chief Financial Officer), Paul Burgess (Chief Operating Officer & Chief Business Officer)

Tech Stack

Veeva Vault

CMS

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Kailera Therapeutics?

Kailera Therapeutics uses the first.last format on kailera.com, so Jane Smith would be jane.smith@kailera.com.

What obesity pipeline programs is Kailera Therapeutics advancing in Phase 3?

Kailera Therapeutics is advancing ribupatide (KAI-9531), a once-weekly injectable GLP-1/GIP receptor dual agonist, through a global Phase 3 program, making it the company's lead clinical asset in the obesity space.

Where does Kailera Therapeutics source its clinical pipeline?

Kailera Therapeutics in-licensed its pipeline through a strategic collaboration with Jiangsu Hengrui Pharmaceuticals, holding exclusive development and commercialization rights outside of China, Hong Kong, Macau, and Taiwan.

How can I find and verify a Kailera Therapeutics employee's email address?

Since Kailera Therapeutics follows the first.last@kailera.com format, you can construct most addresses directly. A tool like Clay can help verify those addresses and enrich your prospect list with additional contact details before outreach.

Who leads Kailera Therapeutics as its chief executive?

Ron Renaud serves as President and Chief Executive Officer of Kailera Therapeutics, guiding the company's mission to advance a diversified pipeline of GLP-1 therapies for people living with obesity from its Waltham, MA headquarters.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles